Beverly Bell

927 total citations
26 papers, 721 citations indexed

About

Beverly Bell is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Beverly Bell has authored 26 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 11 papers in Pediatrics, Perinatology and Child Health and 8 papers in Molecular Biology. Recurrent topics in Beverly Bell's work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Cancer therapeutics and mechanisms (7 papers). Beverly Bell is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Cancer therapeutics and mechanisms (7 papers). Beverly Bell collaborates with scholars based in United States and Canada. Beverly Bell's co-authors include Allen R. Chauvenet, Joanne Kurtzberg, Teresa J. Vietti, Clinton F. Stewart, William C. Zamboni, Elaine Morgan, Vandana Shashi, Bruce M. Camitta, Stephen J. Lauer and Roger A. Vega and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Beverly Bell

26 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beverly Bell United States	12	238	225	207	175	175	26	721
Aurora Navajas Spain	18	307 1.3×	362 1.6×	380 1.8×	205 1.2×	98 0.6×	41	1.1k
Bleyer Wa United States	12	128 0.5×	239 1.1×	91 0.4×	134 0.8×	279 1.6×	18	704
Adam L. Green United States	19	175 0.7×	136 0.6×	376 1.8×	153 0.9×	121 0.7×	55	923
Marry van den Heuvel‐Eibrink Netherlands	13	243 1.0×	151 0.7×	618 3.0×	51 0.3×	225 1.3×	32	956
Virginia Kimball Dalton United States	8	560 2.4×	657 2.9×	118 0.6×	77 0.4×	91 0.5×	9	905
Paul Brons Netherlands	14	189 0.8×	90 0.4×	144 0.7×	34 0.2×	96 0.5×	33	692
Stephen P. Lowis United Kingdom	19	178 0.7×	94 0.4×	289 1.4×	182 1.0×	156 0.9×	44	773
B. G. Leventhal United States	10	73 0.3×	245 1.1×	110 0.5×	61 0.3×	89 0.5×	12	594
Keiichi Isoyama Japan	15	183 0.8×	289 1.3×	187 0.9×	35 0.2×	46 0.3×	50	705
Elixabet López-López Spain	20	322 1.4×	460 2.0×	430 2.1×	55 0.3×	71 0.4×	48	1.1k

Countries citing papers authored by Beverly Bell

Since Specialization

Citations

This map shows the geographic impact of Beverly Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Bell more than expected).

Fields of papers citing papers by Beverly Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Bell. The network helps show where Beverly Bell may publish in the future.

Co-authorship network of co-authors of Beverly Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Bell. A scholar is included among the top collaborators of Beverly Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Bell. Beverly Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Tamekia L., Bruce M. Camitta, Barbara L. Asselin, et al.. (2014). Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 36(5). 353–361. 7 indexed citations

Duffner, Patricia K., F. Daniel Armstrong, Lu Chen, et al.. (2013). Neurocognitive and Neuroradiologic Central Nervous System Late Effects in Children Treated on Pediatric Oncology Group (POG) P9605 (Standard Risk) and P9201 (Lesser Risk) Acute Lymphoblastic Leukemia Protocols (ACCL0131). Journal of Pediatric Hematology/Oncology. 36(1). 8–15. 58 indexed citations

Rubnitz, Jeffrey E., David Wichlan, Meenakshi Devidas, et al.. (2008). Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. Journal of Clinical Oncology. 26(13). 2186–2191. 53 indexed citations

Chauvenet, Allen R., Paul L. Martin, Meenakshi Devidas, et al.. (2007). Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood. 110(4). 1105–1111. 40 indexed citations

Williams, Hadyn T., et al.. (2007). F-18-FDG-PET/CT Leads to Diagnosis of Cryptococcal Pneumonia Where Recurrent Metastatic Rhabdomyosarcoma was Suspected. Clinical Nuclear Medicine. 32(5). 401–403. 9 indexed citations

Bell, Beverly, et al.. (2004). A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group). Pediatric Blood & Cancer. 43(2). 105–109. 20 indexed citations

Chauvenet, Allen R., et al.. (2003). Vincristine-Induced Neuropathy as the Initial Presentation of Charcot-Marie-Tooth Disease in Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study. Journal of Pediatric Hematology/Oncology. 25(4). 316–320. 97 indexed citations

Bell, Beverly, Myron Chang, & Howard J. Weinstein. (2001). A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study. Medical and Pediatric Oncology. 37(2). 103–107. 22 indexed citations

Brown, Ronald T., Avi Madan‐Swain, Gary A. Walco, et al.. (1998). Cognitive and Academic Late Effects Among Children Previously Treated for Acute Lymphocytic Leukemia Receiving Chemotherapy as CNS Prophylaxis. Journal of Pediatric Psychology. 23(5). 333–340. 115 indexed citations

10.

Saylors, Robert L., Clinton F. Stewart, William C. Zamboni, et al.. (1998). Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.. Journal of Clinical Oncology. 16(3). 945–952. 63 indexed citations

11.

Tubergen, David G., Clinton F. Stewart, Charles B. Pratt, et al.. (1996). Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid Tumors. Journal of Pediatric Hematology/Oncology. 18(4). 352–361. 112 indexed citations

12.

Baruchel, Sylvain, Mark L. Bernstein, V. Michael Whitehead, et al.. (1995). A Phase I study of acivicin in refractory pediatric solid tumors. Investigational New Drugs. 13(3). 211–215. 10 indexed citations

13.

Bell, Beverly, et al.. (1995). Hemophilia: An Updated Review. Pediatrics in Review. 16(8). 290–298. 12 indexed citations

14.

Bernstein, Mark L., V. Michael Whitehead, Holcombe E. Grier, et al.. (1993). Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study. Cancer. 72(5). 1790–1794. 4 indexed citations

15.

Furman, Wayne L., Douglas Strother, Kenneth L. McClain, et al.. (1993). Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 11(11). 2205–2210. 39 indexed citations

16.

Bell, Beverly, Harry W. Findley, J. Krischer, et al.. (1991). Phase II Study of 13-cis-Retinoic Acid in Pediatric Patients with Acute Nonlymphocytic Leukemia—A Pediatric Oncology Group Study. Journal of Immunotherapy. 10(2). 77–83. 9 indexed citations

17.

Falletta, J M, Barbara Cushing, S J Lauer, et al.. (1990). Phase I evaluation of diaziquone in childhood cancer. Investigational New Drugs. 8(2). 167–170. 8 indexed citations

18.

Green, Daniel M., Jeffrey P. Krischer, Beverly Bell, et al.. (1990). Phase I study of a 120‐hour continuous intravenous infusion of 5‐fluorouracil in pediatric patients with recurrent solid tumors: A pediatric oncology group study. Medical and Pediatric Oncology. 18(4). 321–324. 7 indexed citations

19.

Bell, Beverly & M. A. Whitehead. (1986). Chemotherapy of Childhood Acute Lymphoblastic Leukemia. Developmental Pharmacology and Therapeutics. 9(3). 145–170. 4 indexed citations

20.

Williams, D.L., Beverly Bell, & Abdelsalam H. Ragab. (1985). Clitorism at presentation of acute nonlymphocytic leukemia. The Journal of Pediatrics. 107(5). 754–755. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact